Allergan PLC (AGN) on Thursday reported a second-quarter loss of $243.1 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Dublin-based company said it had a loss of 80 cents. Earnings, adjusted for non-recurring costs, came to $4.41 per share.
Continue Reading Below
The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for earnings of $4.41 per share.
The drugmaker posted revenue of $5.76 billion in the period.
Allergan shares have increased 31 percent since the beginning of the year, while the Standard & Poor's 500 index has increased 2 percent. The stock has climbed 57 percent in the last 12 months.
This story has been corrected to show the name of the company is Allergan, not Activis. The company changed its name in last month.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGN at http://www.zacks.com/ap/AGN
Keywords: Allergan, Earnings Report